# IV Haloperidol for the Treatment of Headache in the ED

> **NCT02747511** · PHASE4 · COMPLETED · sponsor: **Western Michigan University School of Medicine** · enrollment: 118 (actual)

## Conditions studied

- Headache
- Migraine Disorders

## Interventions

- **DRUG:** Haloperidol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02747511
- **Lead sponsor:** Western Michigan University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2017-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02747511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02747511, "IV Haloperidol for the Treatment of Headache in the ED". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02747511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*